Literature DB >> 18027159

Repeatability of inflammatory parameters in induced sputum of COPD patients.

Martin Boorsma1, René Lutter, Marianne A van de Pol, Theo A Out, Henk M Jansen, René E Jonkers.   

Abstract

RATIONALE: Limited information is available on repeatability of inflammatory parameters in whole induced sputum samples from patients with COPD.
OBJECTIVES: To study short-term and long-term repeatability in induced sputum samples in 22 patients with moderate to severe, stable COPD (mean age 64 yr, mean FEV(1) 1.91 L=65% of predicted). Samples were collected on 71 occasions twice within 1 to 7 days (mean 3.8 days) and on 12 occasions twice with an interval of 3 months while clinically stable. Cell differentials, markers of neutrophilic and eosinophilic inflammation, respiratory membrane permeability and size-selective permeation were assessed.
FINDINGS: Parameters of permeability and of size-selective permeation, % eosinophils and % neutrophils showed the best short-term repeatability with intra-class correlation coefficients (Ri) of 0.61 to 0.90, followed by total cell count (TCC) with Ri of 0.52. Repeatability of soluble cell activation markers was less satisfactory (Ri 0.34 to 0.52). Mean short-term within-patient variability for TCC and permeability was approximately 2-fold and for cell activation markers 3-fold; mean between-patients variability was twice as high. Inducing sputum slightly enhanced eosinophil numbers and % neutrophils and decreased % macrophages in successive IS samples. Long-term repeatability was comparable to short-term repeatability but variability increased.
CONCLUSIONS: Repeatability of parameters assessed in whole sputum is similar as reported previously for sputum plugs. In COPD an induced sputum procedure has a minor pro-inflammatory effect. The current data facilitates power calculations but also indicates that studies using inflammatory markers in sputum may easily be underpowered.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18027159     DOI: 10.1080/15412550701597720

Source DB:  PubMed          Journal:  COPD        ISSN: 1541-2563            Impact factor:   2.409


  8 in total

1.  Characterization of the inflammatory response to inhaled lipopolysaccharide in mild to moderate chronic obstructive pulmonary disease.

Authors:  Vandana Gupta; Antonia Banyard; Aoibheann Mullan; Srividya Sriskantharajah; Thomas Southworth; Dave Singh
Journal:  Br J Clin Pharmacol       Date:  2015-05       Impact factor: 4.335

2.  Sputum Eosinophil Level among Healthy Individuals Visiting Medicine Outpatient Department of a Tertiary Care Centre: A Descriptive Cross-sectional Study.

Authors:  Subash Pant; Prinsa Shrestha; Rajat Acharya; Pranita Gurung; Arpana Neopane
Journal:  JNMA J Nepal Med Assoc       Date:  2022-03-11       Impact factor: 0.556

3.  Local and systemic oxidative stress status in chronic obstructive pulmonary disease patients.

Authors:  Mian Zeng; Yue Li; Yujie Jiang; Guifang Lu; Xiaomei Huang; Kaipan Guan
Journal:  Can Respir J       Date:  2013 Jan-Feb       Impact factor: 2.409

4.  Airway inflammation and mannitol challenge test in COPD.

Authors:  Selma B de Nijs; Niki Fens; Rene Lutter; Erica Dijkers; Frans H Krouwels; Barbara S Smids-Dierdorp; Reindert P van Steenwijk; Peter J Sterk
Journal:  Respir Res       Date:  2011-01-18

5.  Ageing and long-term smoking affects KL-6 levels in the lung, induced sputum and plasma.

Authors:  Nobuhisa Ishikawa; Witold Mazur; Tuula Toljamo; Katri Vuopala; Mikko Rönty; Yasushi Horimasu; Nobuoki Kohno; Vuokko L Kinnula
Journal:  BMC Pulm Med       Date:  2011-05-11       Impact factor: 3.317

6.  Neutrophil extracellular trap (NET) formation characterises stable and exacerbated COPD and correlates with airflow limitation.

Authors:  Fikreta Grabcanovic-Musija; Astrid Obermayer; Walter Stoiber; Wolf-Dietrich Krautgartner; Peter Steinbacher; Nicole Winterberg; Arne Cornelius Bathke; Michaela Klappacher; Michael Studnicka
Journal:  Respir Res       Date:  2015-05-22

Review 7.  Eosinophilic airway inflammation: role in asthma and chronic obstructive pulmonary disease.

Authors:  Leena George; Christopher E Brightling
Journal:  Ther Adv Chronic Dis       Date:  2016-01       Impact factor: 5.091

8.  The repeatability of interleukin-6, tumor necrosis factor-alpha, and C-reactive protein in COPD patients over one year.

Authors:  Umme Kolsum; Kay Roy; Cerys Starkey; Zoë Borrill; Nick Truman; Jørgen Vestbo; Dave Singh
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-04-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.